Connect with us

Technology

A $3.5M Research Chair to Remediate Québec’s Soil and Groundwater

Published

on

INRS and its partners join forces to develop sustainable solutions to a critical environmental challenge

QUÉBEC CITY, July 15, 2026 /CNW/ – The Institut national de la recherche scientifique (INRS), in collaboration with the Ministère de l’Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs (MELCCFP), announces a new industrial research chair for the in situ treatment of soil and groundwater contaminated by persistent and emerging pollutants. The initiative, launched with the support of TechnoRem, a subsidiary of ABS, aims to address one of Québec’s most pressing environmental challenges: the sustainable remediation of contaminated sites.

A key environmental issue

Contaminated soil and groundwater are a considerable environmental liability for Québec. Municipalities, government agencies, and developers must contend with complex contamination issues, emerging pollutants, and limited–particularly financial–resources. In situ treatment technologies, which allow decontamination to proceed directly on site, offer an ecological, cost‑effective, and context‑appropriate solution.

Under the leadership of Professor Richard Martel, a recognized expert in hydrogeology, the Chair’s team will develop new knowledge and strategies to improve in situ treatment methods and identify new applications.

“In today’s environmental context, in situ decontamination of soil and groundwater is critically important. The easiest sites to decontaminate are already being treated, but persistent contaminants–buried deep underground or located beneath infrastructure–are stubbornly hard to get at and remove. With this Chair, we aim to address Québec’s needs by working with industry to develop innovative and sustainable approaches capable of treating these pollutants directly at the source.”
 — Richard Martel, INRS Professor and Holder of the Industrial Research Chair in In Situ treatment of soil and groundwater contaminated by persistent and emerging pollutants 

The Research Chair will receive $3.5 million in funding from MELCCFP and ABS‑TechnoRem over the next five years.

An exciting partnership for the advancement of knowledge

The Chair brings together professors, engineers, and field specialists around a common goal: accelerating the development of workable and effective in situ decontamination solutions adapted to Québec’s realities.

At INRS’s Centre Eau Terre Environnement, a multidisciplinary team will leverage its expertise in site remediation, environmental biotechnology, industrial bioprocesses, modelling, and engineering in collaboration with other universities, including Polytechnique Montréal and UQAT (Université du Québec en Abitibi-Témiscamingue). The partnership with TechnoRem adds vital operational expertise to test and validate new solutions under real‑world conditions and support their transfer to end‑users.

“In situ decontamination is essential for rehabilitating polluted sites and ensuring they can be used safely. For over 35 years, our commitment has been to improve quality of life for Quebecers. This new Chair is a reflection of our pride and our drive to innovate. With the vision and expertise of our partners, we will strengthen Québec’s leadership in remediation solutions and continue to develop cutting‑edge approaches to meet tomorrow’s challenges.”
 — Jean‑Marc Lauzon, principal director, ABS‑TechnoRem

Research activities will follow a complete development pathway: laboratory research, intermediate‑scale testing in 2D and 3D sand tanks, and then pilot‑scale field trials. The Chair is committed to driving innovation in in situ treatment.

Tackling the most worrisome contaminants

The research will focus on substances of particular concern, including per‑ and polyfluoroalkyl substances (PFAS), polychlorinated biphenyls (PCBs), petroleum hydrocarbons, dioxins, furans, perchlorates, brominated flame retardants, plasticizers, and selected pharmaceutical products. These contaminants enter the environment following accidental spills or as a result of earlier industrial practices.

They are persistent and toxic to human health and ecosystems and require treatment methods adapted to Québec’s colder climate and the remoteness of some of its treatment sites.

Big benefits for Québec

Treating contaminants directly at the source will sustainably reduce Québec’s environmental liability while avoiding offloading the problem to landfill sites. Less excavation and transportation of contaminated soil will also reduce greenhouse gas emissions and related nuisances.

Local communities will enjoy reduced exposure risk without need for relocation and with no disruption to surface activities. Economically, the Chair will contribute to the development of a Québec in situ treatment industry while fostering innovation and creating specialized jobs, particularly in remote regions.

“Implementation of the 2023–2029 Action Plan under the Soil Protection and Contaminated Land Rehabilitation Policy marks a decisive milestone for Québec. Land decontamination and redevelopment are strategic and essential priorities in efforts to revitalize our communities. The industrial research chair in in situ treatment will play a decisive role in this regard by accelerating innovation, strengthening Québec expertise, deploying sustainable solutions adapted to our environment, and achieving the Action Plan’s objective of increasing the number of sites rehabilitated through in situ technologies.”
 — Marie Andrée Vézina, Director, Soil Protection and Industrial Remediation Branch, MELCCFP

“This funding reflects the Ministry’s confidence in INRS and in the work it has entrusted us to carry out. Backed by an exceptional team, recognized expertise in sustainable site remediation, and strong research partnerships with collaborators across sectors, we are accelerating the development of solutions that address Québec’s needs. This Chair strengthens our Centre, brings research, engineering, and industry closer together, and aligns fully with the mission of INRS: putting science to work for Québec’s economic, social, and cultural development”
 — Louis‑César Pasquier, Director, Eau Terre Environnement Research Centre, INRS

INRS will also play a central role in training the next generation of scientists to meet the growing need for sustainable decontamination.

The Chair is aligned with the MELCCFP’s 2023–2029 Action Plan, which seeks to foster innovation and sustainable rehabilitation methods.

About INRS  

INRS is an academic institution dedicated exclusively to research and graduate training in strategic niches in Québec. For 55 years it has contributed to the economic, social and cultural development of Québec. INRS is the Canadian leader in research intensity. The school is made up of four interdisciplinary research and training centres located in Québec City, Montréal, Laval, and Varennes, which focus on the following strategic areas: Eau Terre Environnement, Énergie Matériaux Télécommunications, Urbanisation Culture Société, and Armand-Frappier Santé Biotechnologie. Its community includes more than 1,500 students, postdoctoral fellows, faculty, and staff. 

About the MELCCFP

The Ministère de l’Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs (MELCCFP) is responsible for protecting the environment, ensuring the conservation and enhancement of biodiversity, and playing a leading role in climate action and the transition to a low-carbon future. Through a sustainable development approach, the Ministry contributes to addressing Québec’s key environmental, social, and economic challenges.

About TechnoRem

Founded in 1996, TechnoRem brings together approximately 50 specialized professionals and technicians whose expertise spans geology, hydrogeology, water resource management, water treatment, civil engineering, mechanical and process engineering, geochemistry, mathematical modelling, and the characterization and remediation of contaminated sites.

Driven by scientific rigour and a passion for innovation, TechnoRem supports a diverse clientele in meeting complex environmental and sustainability challenges through forward-looking, tailored solutions. The company provides consulting, design, and implementation services for integrated solutions in environmental remediation engineering, as well as the management, conservation, and protection of groundwater resources. Its work is underpinned by a strong understanding of subsurface systems and a commitment to innovation.

Since joining Groupe ABS in 2022, TechnoRem has gained access to an extensive pool of specialized expertise in geosciences, materials engineering, and industrial hygiene, further strengthening its ability to deliver comprehensive solutions to environmental challenges.

SOURCE Institut National de la recherche scientifique (INRS)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment

Published

on

By

WASHINGTON, July 15, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that NEREUS™ (tradipitant), the first new prescription medication approved for prevention of vomiting induced by motion in 47 years, will sponsor the No. 47 entry in the NTT IndyCar Series with Rahal Letterman Lanigan Racing.

The partnership aligns NEREUS’™ breakthrough innovation in motion relief with the high-speed world of IndyCar racing, where focus and stability are essential.

This sponsorship marks a symbolic milestone: 47 years since the last new motion sickness treatment was introduced in the United States. NEREUS™ represents a modern advancement as a selective NK-1 receptor antagonist designed to prevent vomiting induced by motion, offering a new option for millions who experience motion sickness during travel.

“Partnering with the No. 47 car perfectly captures this historic moment and our shared commitment to performance under challenging conditions,” said Mihael H. Polymeropoulos, M.D., President, CEO and Chairman of the Board of Vanda. 

The NEREUS™-branded No. 47 IndyCar will feature prominent sponsorship visibility across select NTT IndyCar Series events in 2026.

About NEREUS™ (tradipitant)

NEREUS™ is an oral NK-1 receptor antagonist FDA-approved for the prevention of vomiting induced by motion in adults. It is the first new pharmacologic treatment approved for this indication in over four decades.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

About Rahal Letterman Lanigan Racing

Rahal Letterman Lanigan Racing is a championship-winning team competing in the NTT IndyCar Series.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

Follow us on X @vandapharma

View original content to download multimedia:https://www.prnewswire.com/news-releases/nereus-powers-forward-sponsors-no-47-indycar-entry-celebrating-47-years-since-last-new-us-motion-sickness-treatment-302826721.html

SOURCE Vanda Pharmaceuticals Inc.

Continue Reading

Technology

VIAVI Announces Date for Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results

Published

on

By

CHANDLER, Ariz., July 15, 2026 /PRNewswire/ — Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) will announce its fiscal fourth quarter and fiscal year 2026 financial results for the period ended June 27, 2026, on Wednesday, August 5, 2026, after the close of market.

The Company will host an earnings call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast of the call and the replay will be available on the VIAVI website at https://investor.viavisolutions.com. The quarterly earnings press release, supplementary slides and historical financial tables will be posted under the “Quarterly Results” section.

To participate via telephone:

Toll-Free Dial-In Number:

1 (833) 461-5787

Toll Dial-In Number:

1 (585) 542-9983

Conference ID:

687 725 628

About VIAVI Solutions
VIAVI (NASDAQ: VIAV) is a global leader in test and measurement and optical technologies. Our test, monitoring, assurance, and resilient position, navigation and timing solutions enable and secure critical infrastructure ranging from data center ecosystems and communication networks to military, aerospace, railway and first responder communications. In addition, we develop and advance technologies used in high-volume optical applications across anti-counterfeiting, consumer electronics, aerospace, industrial and automotive end markets.

Learn more about VIAVI at www.viavisolutions.com. Follow us on VIAVI PerspectivesLinkedIn and YouTube.

Investors Contact:
Vibhuti Nayar, 408-404-6305; investor.relations@viavisolutions.com
Press Contact:
Amit Malhotra, 202-341-8624; amit.malhotra@viavisolutions.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/viavi-announces-date-for-fiscal-fourth-quarter-and-fiscal-year-2026-financial-results-302822275.html

SOURCE VIAVI Financials

Continue Reading

Technology

The American Council of the Blind to Distribute Ray-Ban Meta AI Glasses to Blind Veterans in St. Louis on July 27

Published

on

By

ALEXANDRIA, Va., July 15, 2026 /PRNewswire/ — The American Council of the Blind is proud to partner with Meta and the Blinded Veterans Association (BVA) to distribute Ray-Ban Meta AI glasses to eligible veterans who are blind during the upcoming 2026 ACB Conference and Convention in St. Louis.

The distribution will take place on Monday, July 27, from 1 to 5 p.m. CT at the Hyatt St. Louis at The Arch in downtown St. Louis. Eligible veterans can receive Ray-Ban Meta AI glasses at no cost while supplies last and a complimentary day pass to the ACB convention for July 27.

The initiative is part of Meta’s commitment to donate Ray-Ban Meta AI glasses to 130,000 blinded veterans worldwide, expanding access to technology that can support greater independence, access to information, and everyday tasks. As a distribution partner, ACB will also provide access to training resources for veterans receiving Meta glasses.

“Supporting veterans who are blind or have low vision has long been an important part of ACB’s mission,” said ACB Executive Director Scott Thornhill. “We are honored to partner with Meta and BVA to help connect veterans with innovative technology that can make a meaningful difference in their daily lives.”

Ray-Ban Meta AI glasses combine a lightweight, hands-free design with built-in artificial intelligence to help users complete everyday tasks more independently. Wearers can ask the glasses to describe their surroundings, read printed text, identify objects, and capture photos or videos.

To receive a pair of Ray-Ban Meta AI glasses at the July 27 distribution event, individuals must provide proof of military service, acknowledge legal blindness, and own a compatible smart phone.

A day pass to the ACB Conference and Convention with access to the Exhibit Hall will be available for recipients.

For more details about the Ray-Ban Meta AI glasses distribution, visit https://www.acb.org/glasses.

About the American Council of the Blind

The American Council of the Blind is a national member-driven consumer organization representing Americans who are blind or have low vision. With 65 affiliates, ACB strives to increase independence, security, equality of opportunity, and to improve the quality of life for all people who are blind or have low vision. For more information, visit https://www.acb.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-american-council-of-the-blind-to-distribute-ray-ban-meta-ai-glasses-to-blind-veterans-in-st-louis-on-july-27-302826844.html

SOURCE American Council of the Blind

Continue Reading

Trending